Glonway, August 17 | Federal Pharmaceuticals opened 4.5% higher at HK$6.46, with a total market capitalization of about HK$11.74 billion. Federal Pharmaceuticals is Yingxi. The Group's net profit for the first half of 2023 is expected to be about 1.2 billion yuan, an increase of 90.8% over the same period last year of about 629 million yuan. According to the announcement, the increase in profit was mainly due to the steady increase in the turnover of various business segments of the Group during the period. Among them, sales of intermediate products and APIs continued to grow, and the recovery in demand represented by overseas markets led to a steady rise in market prices of related products.
港股异动丨联邦制药高开4.5% 预计上半年净溢利同比增长90.8%
Changes in Hong Kong stocks: Federal Pharmaceuticals opened 4.5% higher, and net profit for the first half of the year is expected to increase 90.8% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.